For instance, Chuling Li and collaborators, through ROC curve analysis, found that lncRNA GAS5 from exosomes combined with carcinoembryonic antigen could be used to distinguish patients with stage I from other stages of non-small cell lung cancer patients with an AUC of 0.822 [29]. This evidence concerns the gene GAS5 and non-small cell lung carcinoma.